214 related articles for article (PubMed ID: 21736693)
1. Obesity and prostate enlargement in men with localized prostate cancer.
Kopp RP; Han M; Partin AW; Humphreys E; Freedland SJ; Parsons JK
BJU Int; 2011 Dec; 108(11):1750-5. PubMed ID: 21736693
[TBL] [Abstract][Full Text] [Related]
2. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
Freedland SJ; Platz EA; Presti JC; Aronson WJ; Amling CL; Kane CJ; Terris MK
J Urol; 2006 Feb; 175(2):500-4; discussion 504. PubMed ID: 16406980
[TBL] [Abstract][Full Text] [Related]
3. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
4. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
Loeb S; Yu X; Nadler RB; Roehl KA; Han M; Hawkins SA; Catalona WJ
J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013
[TBL] [Abstract][Full Text] [Related]
5. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
Freedland SJ; Grubb KA; Yiu SK; Humphreys EB; Nielsen ME; Mangold LA; Isaacs WB; Partin AW
J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988
[TBL] [Abstract][Full Text] [Related]
6. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
Freedland SJ; Bañez LL; Sun LL; Fitzsimons NJ; Moul JW
Prostate Cancer Prostatic Dis; 2009; 12(3):259-63. PubMed ID: 19581922
[TBL] [Abstract][Full Text] [Related]
7. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
Freedland SJ; Grubb KA; Yiu SK; Nielsen ME; Mangold LA; Isaacs WB; Epstein JI; Partin AW
J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
[TBL] [Abstract][Full Text] [Related]
8. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
9. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
10. Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?
Lee SE; Lee WK; Jeong MS; Abdullajanov M; Kim DS; Park HZ; Jeong SJ; Yoon CY; Byun SS; Choe G; Hong SK
BJU Int; 2011 Apr; 107(8):1250-5. PubMed ID: 20880194
[TBL] [Abstract][Full Text] [Related]
11. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
12. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.
De Nunzio C; Freedland SJ; Miano L; Finazzi Agrò E; Bañez L; Tubaro A
Eur J Surg Oncol; 2011 Dec; 37(12):1025-9. PubMed ID: 21963050
[TBL] [Abstract][Full Text] [Related]
13. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
14. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
Freedland SJ; Terris MK; Platz EA; Presti JC
Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
16. Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy?
Mitchell CR; Umbreit EC; Rangel LJ; Bergstralh EJ; Karnes RJ
Urology; 2011 Oct; 78(4):868-72. PubMed ID: 21843902
[TBL] [Abstract][Full Text] [Related]
17. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
[TBL] [Abstract][Full Text] [Related]
18. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
[TBL] [Abstract][Full Text] [Related]
19. Influence of obesity on tumour volume in patients with prostate cancer.
Capitanio U; Suardi N; Briganti A; Gallina A; Abdollah F; Lughezzani G; Salonia A; Freschi M; Montorsi F
BJU Int; 2012 Mar; 109(5):678-84. PubMed ID: 21777363
[TBL] [Abstract][Full Text] [Related]
20. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]